A new study, presented today at the AATS 101st Annual Meeting, found that patients treated surgically for segmental Chronic Thromboembolic Pulmonary Hypertension (CTEPH) had excellent outcomes with ...
Qureight, a techbio company advancing the understanding of lung and heart disease through application of its AI-powered ...
https://doi.org/10.4103/2045-8932.97594 • https://www.jstor.org/stable/10.4103/2045-8932.97594 Copy URL AbstractPulmonary hypertension as a result of chronic ...
Qureight’s Vascul8 model has been validated in a peer-reviewed study marking a significant advance in the treatment of ...
Marius Berman, Deepa Gopalan, Linda Sharples, Nick Screaton, Caroline Maccan, Karen Sheares, Joanna Pepke-Zaba, John Dunning, Steven Tsui, David P. Jenkins Pulmonary ...
Study published in ‘American Journal of Respiratory Cell and Molecular Biology’ validates Qureight’s deep-learning models and imaging platform beyond fibrotic lung disease, into new therapeutic areas ...
Backround A 40-year-old woman presented with dyspnea in the fifth month of pregnancy followed by a sudden onset of pleuritic chest pain 2 weeks postpartum. She was diagnosed as having pulmonary ...
There is the potential for serious complications with balloon pulmonary angioplasty, but it works well enough for use in the NHS for patients with chronic thromboembolic pulmonary hypertension in whom ...
Surgeons at a hospital in Cambridgeshire have performed 500 operations to clear blood clots on the lungs of seriously ill people. Papworth Hospital is the only centre in the UK which performs the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback